苜蓿夜蛾中肠丝氨酸蛋白酶cDNA的克隆、序列分析及原核表达

【目的】本研究旨在从苜蓿夜蛾Heliothis viriplaca中肠克隆出丝氨酸蛋白酶（serine protease, SP）基因的cDNA序列,测定原核表达后的蛋白经纯化及复性后的活性。【方法】运用RT-PCR和cDNA末端快速扩增方法（rapid amplification of cDNA ends, RACE）克隆苜蓿夜蛾幼虫中肠丝氨酸蛋白酶cDNA全序列,用大肠杆菌Escherichia coli表达系统进行表达。重组蛋白经纯化后,利用梯度透析法进行复性,以BApNA为底物,进行活性测定。【结果】克隆获得的苜蓿夜蛾中肠丝氨酸蛋白酶基因命名为HvSP（GenBank登录号：JX866720）,该基因全长880 bp,开放阅读框长762 bp,编码254个氨基酸,推测分子量和pI值分别为26.9 kDa和9.49。由HvSP推导的氨基酸与鳞翅目昆虫SP氨基酸序列的一致性在52%~95%之间,其中与棉铃虫Helicoverpa armigera SP（GenBank登录号：CAA72962）的氨基酸序列一致性最高,达95%。成功构建重组载体pET21b-HvSP进行原核表达,Western-blot鉴定确定为目的蛋白。蛋白可溶性分析发现重组蛋白为包涵体。在Glycine-NaOH缓冲液中,当pH为10.0时,复性的重组蛋白活性达到最高,为35.74 U/mL。【结论】本研究在苜蓿夜蛾体内获得了一个新的丝氨酸蛋白酶基因,且原核表达后的重组蛋白经过变性、纯化及复性后具有活性。该结果为进一步研究丝氨酸蛋白酶在鳞翅目昆虫体内的生理功能奠定了基础。     

Henna基因突-变是导致北京紫眼果蝇眼部蝶呤含量减少的重要原因

苯丙氨酸羟化酶被认为参与黑腹果蝇眼部蝶呤代谢,但是始终都缺乏有力证据．Henna是苯丙氨酸羟化酶的编码基因,“北京紫眼”果蝇（Hnbp）是Henna基因的一个隐性突变体,Hn^bp突变形成的原因是Henna基因的第二外显子上具有插入片段．在Hn^bp中,其编码产物的Biopterin—Hydroxyl功能域中增加了15个氨基酸残基．蛋白预测结果显示,插入的残基改变了原有的蛋白结构,这种变化很可能降低了苯丙氨酸羟化酶与四氢生物蝶呤结合的能力．为了恢复突变表型,利用UAS—GAL4转基因体系使野生型Henna基因在Hn^bp的背景下表达．在双拷贝的转基因系GMR—GAL4 UAS—Henna／UAS—Henna;Hn^bp／Hn^bp中,突变表型得到完全恢复：果蝇的眼色由突变体的紫色恢复到野生型的红色,蝶呤含量也从突变体的30％升至98％,与野生型差异不显著（P〉0．05）．上述实验结果充分说明,Henna基因突变是导致Hn^bp突变体眼部喋呤含量降低的重要原因,为苯丙氨酸羟化酶参与果蝇眼部蝶呤代谢提供了体内实验的直接证据．     

四氢生物蝶呤与血管内皮功能异常

血管内皮功能异常突出表现为内皮依赖性血管舒张功能障碍 ,主要由NO减少及氧自由基增加所致。四氢生物蝶呤 (tetrahydrobiopterin ,BH4 )是NO合酶 (NOS)的必要辅助因子 ,影响NO和氧自由基生成。BH4充足时 ,NOS催化底物L 精氨酸和O2 生成L 胍氨酸和NO ;BH4缺乏时 ,NOS则发生脱偶联 (uncoupling) ,主要催化超氧阴离子产生。BH4缺乏是高血压、糖尿病、动脉粥样硬化等疾病中内皮功能异常的重要原因 ,用BH4替代治疗提高内皮细胞内BH4水平可有效改善内皮功能 ,可望为保护血管内皮功能提供有效途径     

Gch在喋啶代谢通路中参与鱼类体色形成的研究

鸟苷三磷酸环化水解酶 (GTP cyclohydrolase,Gch)是具有GTP-cyclohydro结构域的蛋白酶,广泛存在于脊椎动物和无脊椎动物中。哺乳动物和鸟类中只具有Gch1,硬骨鱼类和两栖动物中Gch1存在旁系同源的Gch2和Gch3,且功能存在差异。Gch是以鸟苷三磷酸为底物,最终形成四氢生物蝶呤(tetrahydrobiopterin,BH4)的限速酶,而BH4是芳香族氨基酸羟化酶必须的辅助因子,参与多种激素和神经递质的合成。Gch是催化各种蝶呤生物合成的起始步骤,例如皮肤色素、眼色素、甲氨蝶呤、叶黄酸和BH4等,在体内一系列生理病理过程中发挥重要作用。Gch的生理功能与BH4的生物合成有着不可分割的联系,作为BH4生物合成的唯一限速酶,其活性可作为神经元和色素细胞的发育指示物,也是研究色素形成和神经递质生物合成的重要标志。目前,Gch在肿瘤和心血管等疾病的发病机制方面已获得广泛关注和解析,而色素合成和体色调控的作用研究多集中在昆虫方面,在硬骨鱼类中较少。因此,本文将重点对Gch基因、蛋白质、功能以及在鱼类体色方面中的作用进行总结归纳,对深入分析Gch在鱼类体色形成中的作用及后期鱼类体色改良具有重要的指导意义。     

HCV丝氨酸蛋白酶小分子底物构建及GST融合表达

丝氨酸蛋白酶是丙型肝炎病毒重要的功能蛋白和药物作用靶点,其通过分子内（cis）和分子间（trans）方式催化水解前体蛋白,释放病毒功能蛋白。目的：为深入研究病毒蛋白酶活性和抑制剂鉴定需要,实验研究参照丙型肝炎病毒1a亚型菌株蛋白酶天然底物的氨基酸序列特点,设计了一段包含两个天然底物酶切位点的小分子多肽2S,并进行了原核表达。方法：利用PCR方法,合成2S小分子多肽基因,目的基因两端引入BamH I和EcoR I两个限制性酶切位点,双酶切后将基因与表达载体pGEX-4T-2重组,转化大肠杆菌DH5α,经化学诱导进行GST融合蛋白表达,通过亲和层析柱纯化目的蛋白。纯化的GST 2S融合蛋白在体外反应系统进行酶切鉴定,SDS-PAGE和ELISA鉴定酶切结果。结果：PCR合成的小分子底物多肽2S基因,经与表达载体重组后测序,证实基因序列正确。采用0.5mmol/L浓度的IPTG诱导工程菌过夜,获得表达的目的蛋白,经分离纯化得到融合蛋白GST-2S。GST-2S在体外磷酸盐缓冲系统中与丝氨酸蛋白酶反应,15%SDS-PAGE鉴定酶切产物,证实融合蛋白底物条带明显消失,ELISA结果同样说明融合蛋白的底物活性。结论：含有两个天然底物酶切位点的小分子多肽可以替代病毒天然底物,实验结果为丙型肝炎病毒丝氨酸蛋白酶活性研究和酶抑制剂研究奠定了方法学基础。     

UHRF2结构域突变体的原核表达与纯化

目的构建UHRF2各个以结构域为基础的突变体原核表达载体,在大肠埃希菌中表达并对融合蛋白进行纯化和鉴定。方法以pCMV-3xFlag—UHRF2为模板,PCR扩增UHRF2的各个结构域基因片段,各PCR产物经酶切后连接到pGEX-4T-1载体上;将重组载体转化大肠埃希菌（BL21菌株）,IPTG诱导表达各GST融合蛋白,超声波破碎细菌,离心收获蛋白并经谷胱甘肽琼脂糖凝胶4B（glutathione sepharose 4B）亲合纯化;纯化的蛋白经SDS-PAGE电泳后用考马斯亮蓝染色或免疫印记实验鉴定各蛋白表达情况。结果成功构建了UHRF2结构域突变体的原核表达载体,各突变体蛋白表达正确。结论UHRF2各结构域突变体的成功构建便于用GST pull—down实验研究UHRF2参与与其它蛋白相互作用的结构域,为了解UHRF2功能打下了基础。     

原玻璃蝇节杆菌D-氨基酸氧化酶及突变体的酶学特性

【目的】研究原玻璃蝇节杆菌(DSM 20168)中D-氨基酸氧化酶的酶学特性。【方法】通过PCR从原玻璃蝇节杆菌(DSM 15035,20168)中克隆获得D-氨基酸氧化酶基因apdaao-1和apdaao-2,构建原核表达载体,以表达质粒pET-ApDAAO-2为模板,采用QuickChange Site-Directed Mutagenesis技术构建定点突变体,经过原核表达及纯化获得重组型和突变体酶蛋白,分析其酶学特性。【结果】通过原核表达及纯化成功获得了2个重组蛋白和4个突变体酶蛋白,SDS-PAGE检测显示其分子量均约为36 kDa;酶学特性分析表明,ApDAAO-2和突变体蛋白的最适反应温度为30℃;ApDAAO-2和T286A的最适反应pH范围为7.0-11.0,其它突变体为8.0-11.0;ApDAAO-2和突变体都具有较广泛的底物特异性,除T256K的最适底物为D-Phe外,其余均为D-Met;动力学参数测定结果显示,以二级表观常数kcat/Km表示,对于底物D-Met或D-Phe,ApDAAO-2和4个突变体的kcat/Km值均比ApDAAO-1和pKDAAO高数倍以上。【结论】ApDAAO-2及突变体具有比ApDAAO-1和pKDAAO更广泛的底物特异性和较高的催化效率,有一定的商业应用价值。     

高脂血症大鼠四氢生物蝶呤治疗后动脉血管过氧化脂质水平及力学性质改变

目的：探讨长期四氢生物蝶呤（BH4）治疗对高脂血症（HL）大鼠血管脂质过氧化水平及血管力学性质的影响。方法：选用8周龄雄性Wistar大鼠54只,随机分为3组（n=18）：对照组、高脂饮食组（HE组）和高脂饮食并腹腔注射BH4组（HL＋BH4组）,于第8、16和24周龄时每组各杀死6只大鼠测定血脂和脂质过氧化终产物丙二醛（MDA）水平,主动脉血管测量零应力状态张开角、压力-直径关系。结果：至B地治疗后的第16和24周龄,血脂无明显变化,但MDA明显降低（P〈0．01）;HL＋BH4组和HL组比较胸主动脉张开角显著减小（P〈0．01）、压力-直径（P-D）关系曲线上移。结论 BH4可以减轻由于长期高脂血症导致的脂质过氧化,恢复血管弹性,降低血管的结构异常改变。     

家蚕吡哆醛激酶的融合表达与纯化

【目的】吡哆醛激酶（pyridoxal kinase, PLK, EC 2.7.1.35）是维生素B6的关键代谢酶。本研究原核表达家蚕Bombyx mori重组PLK, 为进一步开展家蚕PLK的催化作用机制和表达调控机制的研究奠定基础。【方法】构建家蚕PLK基因融合表达质粒, 转化大肠杆菌Escherichia coli诱导表达, 经Ni²⁺ 亲和层析纯化后, 对融合蛋白的催化活性进行分析。【结果】纯化后的家蚕重组PLK经SDS-PAGE鉴定为单一条带, 比活力为1 800 U/mg, 纯化倍数为40倍。在底物过量的条件下, 该重组酶的体外最适反应温度是50℃; 最适pH为5.5~6; Zn²⁺ 是酶促反应有效的激活剂。【结论】重组家蚕PLK与来源于家蚕组织的PLK具有相同的催化性质。     

家蚕胚胎中胚胎发育因子基因BmEDFG4结构的验证及其结合蛋白的筛选

【目的】本研究旨在通过寻找家蚕Bombyx mori胚胎发育因子(embryonic development factor, EDF)基因BmEDF G-四链体(G-quadruplex, G4)结构的结合蛋白,进一步探究G4结构调控家蚕胚胎发育的可能作用和机制。【方法】通过圆二色谱(circular dichroism, CD)和凝胶迁移实验(electrophoretic mobility shift assay, EMSA)验证G4序列在体外是否形成G4结构;通过启动子活性实验验证BmEDF启动子区G4结构对BmEDF的表达调控的影响;通过qRT-PCR检测BmEDF在家蚕胚胎发育各时期的表达量变化。通过EMSA联合质谱分析可能与BmEDF的G4结构结合的蛋白,然后将与G4结构结合的2个候选蛋白BmeIF4H和BmADDH分别进行基因克隆、表达和纯化,再通过EMSA实验分别验证候选蛋白BmeIF4H和BmADDH与BmEDF的G4结构结合与否。【结果】CD和EMSA实验都证明BmEDF的G4序列在体外可以形成G4结构。启动子活性实验表明BmEDF G4结构的存在对BmEDF转录表达具有正调控的作用。qRT-PCR结果表明BmEDF在产卵后120 h时表达量显著升高。经原核表达纯化,获得BmeIF4H和BmADDH重组蛋白。EMSA实验表明重组蛋白BmeIF4H在体外与BmEDF的G4结构结合,BmADDH不与BmEDF G4结构结合。【结论】家蚕胚胎中的BmeIF4H蛋白可能与BmEDF的G4结构结合。本研究为解析家蚕胚胎发育的DNA高级结构调控机理提供了实验证据。     

A murine model for human sepiapterin-reductase deficiency

Tetrahydrobiopterin (BH(4)) is an essential cofactor for several enzymes, including all three forms of nitric oxide synthases, the three aromatic hydroxylases, and glyceryl-ether mono-oxygenase. A proper level of BH(4) is, therefore, necessary for the metabolism of phenylalanine and the production of nitric oxide, catecholamines, and serotonin. BH(4) deficiency has been shown to be closely associated with diverse neurological psychiatric disorders. Sepiapterin reductase (SPR) is an enzyme that catalyzes the final step of BH(4) biosynthesis. Whereas the number of cases of neuropsychological disorders resulting from deficiencies of other catalytic enzymes involved in BH(4) biosynthesis and metabolism has been increasing, only a handful of cases of SPR deficiency have been reported, and the role of SPR in BH(4) biosynthesis in vivo has been poorly understood. Here, we report that mice deficient in the Spr gene (Spr(-/-)) display disturbed pterin profiles and greatly diminished levels of dopamine, norepinephrine, and serotonin, indicating that SPR is essential for homeostasis of BH(4) and for the normal functions of BH(4)-dependent enzymes. The Spr(-/-) mice exhibit phenylketonuria, dwarfism, and impaired body movement. Oral supplementation of BH(4) and neurotransmitter precursors completely rescued dwarfism and phenylalanine metabolism. The biochemical and behavioral characteristics of Spr(-/-) mice share striking similarities with the symptoms observed in SPR-deficient patients. This Spr mutant strain of mice will be an invaluable resource to elucidate many important issues regarding SPR and BH(4) deficiencies.     

A brain-specific decrease of the tyrosine hydroxylase protein in sepiapterin reductase-null mice--as a mouse model for Parkinson's disease

Sepiapterin reductase (SPR) is an enzyme that acts in the third and final step of tetrahydrobiopterin (BH4) biosynthesis. The human Spr gene locates within the region of 2.5 MB mapped to PARK3, an autosomal dominant form of familial Parkinson’s diseases. In order to explore the role of SPR in the metabolism of BH4, we produced and analyzed Spr-deficient mice. Most of Spr-null mice survived beyond two weeks. Whereas the BH4 contents in the homozygous mutant mice were greatly decreased than those in wild-type and heterozygous mice, the substantial amounts of BH4 were remained even 17 days after delivery. Spr-null mice exhibited severe monoamine deficiencies and a tremor-like phenotype after weaning. The amount of TH protein in the brain of Spr-null mice was less than 10% of wild-type, while TH protein in the adrenal, phenylalanine hydroxylase protein in the liver, and nNOS in the brain were not altered. These data suggest an essential role of SPR in the biosynthesis of BH4, and that the SPR gene could be a candidate gene for PARK3.     

Cloning, expression and enzymatic properties analysis of dihydrofolate reductase gene from the silkworm, Bombyx mori

Tetrahydrobiopterin (BH4) is an essential cofactor for aromatic acid hydroxylases, which control the levels of monoamine neurotransmitters. BH4 deficiency has been associated with many neuropsychological disorders. Dihydrofolate reductase (DHFR) can catalyze 7,8-dihydrobiopterin to 5,6,7,8-tetrahydrobiopterin (BH4) in the salvage pathway of BH4 synthesis from sepiapterin (SP), a major pigment component contained in the integument of silkworm Bombyx mori mutant lemon (lem) in high concentration. In this study, we report the cloning of DHFR gene from the silkworm B. mori (BmDhfr) and identification of enzymatic properties of BmDHFR. BmDhfr is located on scaffold Bm_199 with a predicted gene model BGIBMGA013340, which encodes a 185-aa polypeptide with a predicted molecular mass of about 21?kDa. Biochemical analyses showed that the recombinant BmDHFR protein exhibited high enzymatic activity and suitable parameters to substrate. Together with our previous studies on SP reductase of B. mori (BmSPR) and the lem mutant, it may be an effective way to industrially extract SP from the lem silkworms in large scale to produce BH4 in vitro by co-expressing BmSPR and BmDHFR and using the extracted SP as a substrate in the future.     

Cloning and expression of Bacillus subtilis phage DNA methyltransferase genes in Escherichia coli and B. subtilis

The DNA methyltransferase (Mtase) genes of the temperate Bacillus subtilis phages SPR (wild type and various mutants), phi 3T, rho 11 and SP beta have been cloned and expressed in Escherichia coli and B. subtilis host-plasmid vector systems. Mtase activity has been quantitated in these clones by performing in vitro methylation assays of cell-free extracts. The four-phage Mtase genes differ in the amount of Mtase synthesized when transcribed from their genuine promoters. In B. subtilis as well as in E. coli the SPR Mtase is always produced in smaller amounts than the other phage Mtases. Expression levels of the SPR Mtase are dependent on the strength of the upstream vector promoter sequences. Overproduction of the SPR wild-type and mutant enzymes was achieved in E. coli (inducible expression) by fusions to the lambda pL or the tac promoter and in B. subtilis (constitutive expression) by means of the phage SP02 promoter.     

家蚕小热激蛋白家族成员Hsp23.7基因的克隆与分析

Hsp23.7基因是小热激蛋白家族的成员,本文研究了家蚕BombyxmoriL.的Hsp23.7基因,并对其进行了原核表达,获得了相应分子量的表达产物。推导的开放阅读框编码210个氨基酸,分子量为23.7ku,等电点为5.17。同时,利用实时定量PCR技术对Hsp23.7基因在家蚕不同组织的表达谱进行了鉴定。结果显示Hsp23.7基因在5龄幼虫时期的各组织中都有表达,在卵巢中表达量最高,达到3.64×107拷贝数/μg,其次在脂肪体,翅原基,马氏管中表达量也较高,在血淋巴中表达量最低,仅为7.11×103拷贝数/μg。     

DC-SIGN蛋白在家蚕系统中的表达及生物活性研究

目的：构建人DC-SIGN基因片段的家蚕表达系统,进行目的产物表达、鉴定及生物活性分析。方法：从体外刺激分化的DC细胞中克隆出DC-SIGN cDNA,在家蚕表达载体pBacPAK8的BamHⅠ和EcoRⅠ位点构建成重组质粒pBacPAK8-DC-SIGN,与线性化的Bm-BacPAK6病毒基因组DNA共转染家蚕细胞,空斑筛选得到重组病毒Bm-BacPAK-DC-SIGN,重组病毒感染家蚕细胞BmN,Western blot检测表达产物;HIV-1包膜糖蛋白gp120与表达产物孵育检测其生物活性。结果：构建了稳定表达人DC-SIGN蛋白片段的家蚕杆状病毒表达系统;成功表达了DC-SIGN蛋白片段,且能特异性地与HIV-1包膜糖蛋白gp120结合。结论：成功地在家蚕杆状病毒表达系统中表达了人DC-SIGN蛋白片段,具有天然DC-SIGN蛋白样的生物活性,为其抗体制备及AIDS防治药物的研发奠定了基础。     

Functionally important residues tyrosine-171 and serine-158 in sepiapterin reductase.

The active site of sepiapterin reductase (SPR), which is a member of the NADP(H)-preferring short-chain dehydrogenase/reductase (SDR) family and acts as the terminal enzyme in the biosynthetic pathway of tetrahydrobiopterin cofactor (BH4), was investigated by truncation and site-directed mutagenesis. The truncation mutants showed that N-terminal and C-terminal residues contribute to bind coenzyme and substrate, respectively. The mutant rSPRA29V showed decreased activity; however, the A-X-L-L-S sequence, which has been reported as a putative pterin binding site, was estimated to preferably work as a component in the region for binding coenzyme rather than substrate. Site-directed mutants of rSPRS158D, rSPRY171V, and rSPRK175I showed low, but significant, activity having similar Km values and kcat/Km values less than 25%, for both sepiapterin and NADPH. Both amino acids Tyr-171 and Ser-158 are located within a similar distance to the carbonyl group of the substrate in the crystal structure of mouse SPR, and the double point mutant rSPRY171V+S158D was indicated to be inactive. These results showed that Ser-158, Tyr-171, and Lys-175 contributed to the catalytic activity of SPR, and both Tyr-171 and Ser-158 are simultaneously necessary on proton transfer to the carbonyl functional groups of substrate.     

Interleukin-1beta-induced nitric oxide production and inhibition of insulin secretion in rat islets of langerhans is dependent upon the nitric oxide synthase cofactor tetrahidrobiopterin

Interleukin (IL)-1 beta-induced inhibition of glucose-stimulated insulin secretion in rat islets of Langerhans is mediated in part by nitric oxide (NO). The NO synthase cofactor 5,6,7,8-tetrahydrobiopterin (BH(4)) supports NO synthesis in many cell types and IL-1 beta-induced NO generation and inhibition of insulin secretion have been previously correlated with intracellular BH(4 )levels in rat insulinoma cells. Using rat islets and the beta cell line BRIN-BD11, we have investigated whether synthesis of BH(4) limits IL-1beta-induced NO generation and inhibition of glucose-induced insulin secretion. IL-1 beta-induced NO generation by BRIN cells and islets was reduced by 2,4-diamino-6-hydroxypyrimidine (DAHP), an inhibitor of de novo BH(4) synthesis. Sepiapterin, the substrate for salvage pathway BH(4) synthesis, reversed this inhibitory effect of DAHP in islets but not BRIN cells. DAHP reversed IL-1 beta-induced inhibition of islet insulin secretion, an effect prevented by sepiapterin. We conclude that BH(4) generation is necessary for IL-1 beta-induced NO generation in rat islets and BRIN cells. While a contribution of non-NO mediators cannot be excluded, our results support the proposal that IL-1 beta-induced, NO-mediated inhibition of insulin secretion in rat islets is dependent on the NOS cofactor BH(4).     

组胺H4受体在胃腺癌组织中的表达及临床意义

目的：研究胃癌腺癌（gastric adenocarcinoma,GAC）中组胺H4受体的表达水平及其临床意义。方法：60例GAC组织（病例组）与配对癌旁组织（adjacent normal tissue,ANT）中应用免疫组织化学技术检测组胺H4受体的表达,应用实时荧光定量RT-PCR方法检测组胺H4受体mRNA的表达,统计分析组胺H4受体表达与临床病理特征之间的关系。结果：①胃腺癌组织中组胺H4受体蛋白的阳性表达率（11.7%）显著低于癌旁正常组织（96.7%）。②胃腺癌组织中组胺H4受体mRNA水平较癌旁组织明显降低（p〈0.001）。③组胺H4受体蛋白和mRNA表达异常和肿瘤的病理分级有相关性（p=0.0027和p=0.0011）,也与有无胃周淋巴结转移有关（p〈0.001和p=0.0049）。结论：组胺H4受体在胃腺癌组织有表达异常,表达量与病理分期相关。组胺H4受体表达异常和组胺水平紊乱可能在胃癌发生发展过程中有重要作用。